BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33089869)

  • 1. Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
    Matsumoto K; Urabe Y; Oka S; Inagaki K; Tanaka H; Yuge R; Hayashi R; Kitadai Y; Arihiro K; Shimamoto F; Tanaka S; Chayama K
    Inflamm Bowel Dis; 2021 Apr; 27(5):686-696. PubMed ID: 33089869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular alterations in colitis-associated colorectal neoplasia: study from a low prevalence area using magnifying chromo colonoscopy.
    Shivakumar BM; Kumar BL; Bhat G; Suvarna D; Rao L; Pai CG; Satyamoorthy K
    J Crohns Colitis; 2012 Jul; 6(6):647-54. PubMed ID: 22398042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
    Chakrabarty S; Varghese VK; Sahu P; Jayaram P; Shivakumar BM; Pai CG; Satyamoorthy K
    Br J Cancer; 2017 Jun; 117(1):136-143. PubMed ID: 28524162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia.
    Singhi AD; Waters KM; Makhoul EP; Parian A; Lazarev MG; Proksell SS; Dueker JM; Schwartz MB; Wald AI; Nikiforova MN; Montgomery EA
    Hum Pathol; 2021 Jun; 112():9-19. PubMed ID: 33727167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Fujimori T; Chiba T
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of ulcerative colitis-associated colorectal carcinomas.
    Hirsch D; Hardt J; Sauer C; Heselmeyer-Hadded K; Witt SH; Kienle P; Ried T; Gaiser T
    Mod Pathol; 2021 Jun; 34(6):1153-1166. PubMed ID: 33318582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colitic Cancer Develops Through Mutational Alteration Distinct from that in Sporadic Colorectal Cancer: A Comparative Analysis of Mutational Rates at Each Step.
    Tanaka T; Kobunai T; Yamamoto Y; Emoto S; Murono K; Kaneko M; Sasaki K; Otani K; Nishikawa T; Kawai K; Hata K; Nozawa H; Watanabe T
    Cancer Genomics Proteomics; 2017; 14(5):341-348. PubMed ID: 28871001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of dysplasia in ulcerative colitis.
    Benhattar J; Saraga E
    Eur J Cancer; 1995; 31A(7-8):1171-3. PubMed ID: 7577015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer.
    Sanchez JA; Dejulius KL; Bronner M; Church JM; Kalady MF
    Inflamm Bowel Dis; 2011 Sep; 17(9):1966-70. PubMed ID: 21618350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular landscape of colitis-associated carcinogenesis.
    Saraggi D; Fassan M; Mescoli C; Scarpa M; Valeri N; Michielan A; D'Incá R; Rugge M
    Dig Liver Dis; 2017 Apr; 49(4):326-330. PubMed ID: 28089111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Crohn's disease-associated colorectal carcinogenesis : TP53 mutations and copy number gains of chromosome arm 5p as (early) markers of tumor progression].
    Hirsch D; Gaiser T
    Pathologe; 2018 Dec; 39(Suppl 2):253-261. PubMed ID: 30229283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
    Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
    Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia.
    Shivakumar BM; Chakrabarty S; Rotti H; Seenappa V; Rao L; Geetha V; Tantry BV; Kini H; Dharamsi R; Pai CG; Satyamoorthy K
    BMC Cancer; 2016 Apr; 16():271. PubMed ID: 27080994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
    Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
    Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.
    Hirsch D; Wangsa D; Zhu YJ; Hu Y; Edelman DC; Meltzer PS; Heselmeyer-Haddad K; Ott C; Kienle P; Galata C; Horisberger K; Ried T; Gaiser T
    Clin Cancer Res; 2018 Oct; 24(20):4997-5011. PubMed ID: 29967250
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.
    Yaeger R; Shah MA; Miller VA; Kelsen JR; Wang K; Heins ZJ; Ross JS; He Y; Sanford E; Yantiss RK; Balasubramanian S; Stephens PJ; Schultz N; Oren M; Tang L; Kelsen D
    Gastroenterology; 2016 Aug; 151(2):278-287.e6. PubMed ID: 27063727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical modeling the order of driver gene mutations in colorectal cancer.
    Li L; Hu Y; Xu Y; Tang S
    PLoS Comput Biol; 2023 Jun; 19(6):e1011225. PubMed ID: 37368936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease.
    Rapozo DC; Grinmann AB; Carvalho AT; de Souza HS; Soares-Lima SC; de Almeida Simão T; de Paiva D; Abby F; Albano RM; Pinto LF
    Int J Colorectal Dis; 2009 Oct; 24(10):1141-8. PubMed ID: 19543899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coaltered
    Datta J; Smith JJ; Chatila WK; McAuliffe JC; Kandoth C; Vakiani E; Frankel TL; Ganesh K; Wasserman I; Lipsyc-Sharf M; Guillem J; Nash GM; Paty PB; Weiser MR; Saltz LB; Berger MF; Jarnagin WR; Balachandran V; Kingham TP; Kemeny NE; Cercek A; Garcia-Aguilar J; Taylor BS; Viale A; Yaeger R; Solit DB; Schultz N; D'Angelica MI
    Clin Cancer Res; 2020 Mar; 26(5):1077-1085. PubMed ID: 31719050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.